Citizens & Northern Corp’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-12,289	Closed	-$1.92M	–	104
2020 Q4	$1.92M	Sell	12,289 -29	-0.2%	-$3.73K	0.85%	35
2020 Q3	$1.41M	Sell	12,318 -116	-0.9%	-$12.5K	0.75%	45
2020 Q2	$1.4M	Sell	12,434 -603	-5%	-$64K	0.68%	47
2020 Q1	$1.17M	Buy	13,037 +5,739	+79%	+$563K	0.74%	43
2019 Q4	$789K	Sell	7,298 -5,922	-45%	-$633K	0.39%	62
2019 Q3	$1.29M	Sell	13,220 -479	-3%	-$54K	0.71%	48
2019 Q2	$1.79M	Sell	13,699 -309	-2%	-$39.8K	1%	33
2019 Q1	$1.89M	Buy	14,008 +3,034	+28%	+$377K	1.06%	30
2018 Q4	$1.07M	Sell	10,974 -2,272	-17%	-$269K	0.74%	44
2018 Q3	$1.84M	Sell	13,246 -160	-1%	-$20.1K	1.25%	31
2018 Q2	$1.66M	Buy	13,406 +726	+6%	+$84.8K	1.18%	32
2018 Q1	$1.41M	Buy	12,680 +3,692	+41%	+$441K	1.05%	39
2017 Q4	$1.07M	Buy	8,988 +529	+6%	+$64.4K	0.76%	53
2017 Q3	$1.19M	Buy	8,459 +768	+10%	+$104K	0.9%	49
2017 Q2	$936K	Buy	+7,691	New	+$895K	0.74%	55